Stock LPCN LIPOCINE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Lipocine Inc.

Equities

LPCN

US53630X2036

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-20 pm EDT 		5-day change 1st Jan Change
6.37 USD +5.46% Intraday chart for Lipocine Inc. +20.64% +128.32%
May. 09 Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M MT
May. 09 Lipocine Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
LIPOCINE INC. Stock Lipocine Inc.
 34.07M - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
ARGENX SE Stock argenx SE
 21.6B -
BIONTECH SE Stock BioNTech SE
 22.31B -
GENMAB A/S Stock Genmab A/S
 19.19B
  1. Stock Market
  2. Equities
  3. LPCN Stock
  4. Charts Lipocine Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW